Albany, NY -- (SBWIRE) -- 10/30/2018 -- A fresh report has been added to the wide database of Market Research Report Search Engine (MRRSE). The research study is titled "Global Intravenous Immunoglobulin Market –Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026" which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview.

This report analyzes the current and future prospects of the global intravenous immunoglobulin market. It comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments. The report is a combination of primary and secondary research. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global intravenous immunoglobulin market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

To Get Sample Copy of Report, Click here @ https://www.mrrse.com/sample/2162

A detailed qualitative analysis of factors responsible for driving and restraining market and future opportunities has been provided in the overview section. This section of the report also provides insights into the key trends of the intravenous immunoglobulin market such as shift from intravenous to subcutaneous infusion of immunoglobulin. The key indicators influencing the global intravenous immunoglobulin market taken into consideration include prevalence of immunological disorders, global blood and plasma yield, and geriatric population. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global intravenous immunoglobulin market. The report also highlights key events of the global intravenous immunoglobulin industry. A value chain analysis along with list of major players, hospitals, and distributors is also included in the report.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global intravenous immunoglobulin market for each segment is also reflected. Additionally, market related factors such as increase in preference for product innovation and rise in the number of acute and chronic patients in various regions and historical year-on-year growth have been taken into consideration while estimating the market size.

Based on indication, the global intravenous immunoglobulin market has been segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), primary humoral immunodeficiency, idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, myasthenia gravis, multifocal motor neuropathy (MMN), Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others. In terms of end-user, the global market has been segmented into hospitals, clinics, and home care. The hospitals segment is projected to dominate the market during the forecast period. However, the home care segment is expected to expand at the highest CAGR during the forecast period.

Geographically, the global intravenous immunoglobulin market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, Brazil, and Mexico.

Browse Complete Report with TOC @ https://www.mrrse.com/intravenous-immunoglobulin-market

The report also profiles major players in the global intravenous immunoglobulin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the global intravenous immunoglobulin market is provided in the report. The report also includes a competition matrix that provides insights into recent developments and activities undertaken by the major players. Key companies profiled in the report include Shire plc, ADMA Biologics, Inc., China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB Biomedicaments S.A., Octapharma AG, and Sanquin Plasma Products B.V.

The global intravenous immunoglobulin market has been segmented as follows:

Global Intravenous immunoglobulin Market, by Indication

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Primary Humoral Immunodeficiency

Idiopathic Thrombocytopenic Purpura (ITP)

Guillain-Barre Syndrome

Myasthenia Gravis

Multifocal Motor Neuropathy (MMN)

Kawasaki Disease

Hypogammaglobulinemia

Chronic Lymphocytic Leukemia

Others

Global Intravenous Immunoglobulin Market, by End-user

Hospitals

Clinics

Home Care

 Global Intravenous Immunoglobulin Market, by Region

North America

U.S.

Canada

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

Asia Pacific

Australia & New Zealand

Japan

China

India

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Enquire about this Report @ https://www.mrrse.com/enquiry/2162

About Market Research Reports Search Engine (MRRSE)
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/